AWM
CELG

Aevitas Wealth Management’s Celgene Corp CELG Stock Holding History

Aevitas Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-700
Closed -$66K – 397
2019
Q1 		$66K Buy
700
+600
+600% +$52.5K 0.06% 165
2018
Q4 		$6K Hold
100
– – 0.01% 339
2018
Q3 		$9K Hold
100
– – 0.01% 361
2018
Q2 		$8K Sell
100
-255
-72% -$21.2K 0.01% 349
2018
Q1 		$32K Hold
355
– – 0.03% 214
2017
Q4 		$37K Buy
+355
New +$40.1K 0.04% 205

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Aevitas Wealth Management's CELG Position: Q2 2019 in Review

Aevitas Wealth Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 700 shares — an estimated $66K sold.

Aevitas Wealth Management first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $66K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Aevitas Wealth Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Aevitas Wealth Management sold 700 Celgene Corp shares in Q2 2019, an estimated $66K.
  • Aevitas Wealth Management first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
  • Aevitas Wealth Management's Celgene Corp position peaked at $66K in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Aevitas Wealth Management's 13F filing for Q2 2019, filed 26 Jul 2019.